|

ALE.P02 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Alentis Therapeutics AG1

Indications

  • Squamous Non-small-cell Lung Cancer1
  • Cervical Squamous Cell Carcinoma1
  • Esophageal Squamous Cell Carcinoma1
  • Head and Neck Squamous Cell Carcinoma1
  • Lung Cancer1

Scottsdale, Arizona1 trial

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Mayo Foundation for Medical Education and Research - Mayo Cl

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.